| Literature DB >> 24804339 |
Fabian Melchior Gerster, David Vernez, Pascal Pierre Wild, Nancy Brenna Hopf.
Abstract
BACKGROUND: A growing number of studies have identified cleaners as a group at risk for adverse health effects of the skin and the respiratory tract. Chemical substances present in cleaning products could be responsible for these effects. Currently, only limited information is available about irritant and health hazardous chemical substances found in cleaning products. We hypothesized that chemical substances present in cleaning products are known health hazardous substances that might be involved in adverse health effects of the skin and the respiratory tract.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24804339 PMCID: PMC4096065 DOI: 10.1179/2049396713Y.0000000052
Source DB: PubMed Journal: Int J Occup Environ Health ISSN: 1077-3525
Figure 1Flow-chart of the decision process for including and excluding (non-French- and non-German-speaking cantons, unknown addresses, or uncommon types of cleaning) cleaning companies in the study. 1 Number of cleaning services selected for the study. The table shows response rates by company size.
List of substances identified in section 3 of safety data sheets (SDSs) for 105 selected cleaning products, listed in decreasing order of occurrence in products
| Substance | EU1 | GHS2 | Product3 | |||||||
| Name | CAS | L5 | R6 | C7 | S8 | %9 | Product type | Reference4 | ||
| Isopropyl alcohol | 67-63-0 | F | R11 | Flam.Liq2 | H225 | 1–75 | 16 | FC, GPC, CC, BC, PP | 34–36 | |
| Xi | R20/21/22 | EyeIrrit.2 | H319 | |||||||
| Xn | R36 | STOTSE3 | H336 | |||||||
| R36/38 | ||||||||||
| R67 | ||||||||||
| Diethylene glycol monoethyl ether | 111-90-0 | Xi | R36 | SkinCorr.1B | H314 | 0.1–10 | 15 | PP, GPC, FC | 37–39 | |
| EyeDam1 | H318 | |||||||||
| AcuteTox4 | H302 | |||||||||
| AquaticAcute1 | H400 | |||||||||
| Poly(oxy-1,2-ethanediyl), alpha-tridecyl-omega-hydroxy-, branched | 69011-36-5 | Xn | R22 | EyeDam1 | H318 | 1–20 | 14 | FC, GPC, DP, CC, SRP, BC | na | |
| R41 | AcuteTox4 | H302 | ||||||||
| Dipropylene glycol monomethyl ether | 34590-94-8 | na | na | na | na | 1–20 | 12 | PP, FC, GPC, CC, BC | 40–42 | |
| Citric acid | 77-92-9 | Xi | R36 | EyeIrrit.2 | H319 | 1–30 | 9 | SRP, BC, FC | 43 | |
| Deceth-4 | 26183-52-8 | Xi | R22 | na | na | 1–15 | 9 | SRP, KC, FC, BC, GPC | na | |
| Xn | R41 | |||||||||
| Ethanol | 64-17-5 | F | R11 | Flam.Liq.2 | H225 | 1–20 | 9 | GPC, PP, FC, BC, OSC | 44–46 | |
| Sulfonic acids, C13–17-sec-alkane, sodium salts | 85711-69-9 | Xi | R38R41 | EyeDam1 | H318 | 1–15 | 8 | GPC, FC | na | |
| SkinIrrit.2 | H315 | |||||||||
| SkinCorr.1b | H314 | |||||||||
| AcuteTox4 | H302 | |||||||||
| AquaticAcute1 | H400 | |||||||||
| Monoethanolamine | 141-43-5 | C | R20 | SkinCorr.1b | H314 | 1–15 | 8 | FC, DP, GPC | 9, 47–49 | |
| Xn | R21 | STOTSE3 | H335 | |||||||
| R22 | EyeDam1 | H318 | ||||||||
| R34 | AcuteTox4 | [H302 H312 H332] | ||||||||
| R37 | ||||||||||
| Benzenesulfonic acid, (1-methylethyl)-, sodium salt (1:1) | 28348-53-0 | Xi | R36 | EyeIrrit.2 | H319 | 1–10 | 7 | FC, GPC, CC, BC | na | |
| Alcohols, C13–15-branched and linear, butoxylated ethoxylated | 111905-53-4 | Xi | R36/38 | SkinIrrit2 | H315 | 1–30 | 6 | FC, GPC, CC | na | |
| EyeIrrit.2 | H319 | |||||||||
| Propane | 74-98-6 | F+ | R12 | Flam.Gas1 | H220 | 1–30 | 6 | CC, GPC | 50 | |
| Press.Gas | H280 | |||||||||
| Alcohols, C12–14, ethoxylated | 68439-50-9 | Xn | R22 | EyeDam1 | H318 | 1–10 | 5 | FC, GPC, SRP | na | |
| R41 | AcuteTox4 | H302 | ||||||||
| Benzyl alcohol | 100-51-6 | Xn | R20/22 | EyeIrrit.2 | H319 | 1–20 | 5 | FC, GPC | 51–53 | |
| N | R36 | AcuteTox4 | [H302, H332] | |||||||
| Butane | 106-97-8 | F+ | R12 | Flam.Gas1 | H220 | 15–75 | 5 | CC | 54–56 | |
| Press.Gas | H280 | |||||||||
| Butoxypropanol | 5131-66-8 | Xi | R36/38 | SkinIrrit2 | H315 | 1–30 | 5 | 57 | ||
| EyeIrrit.2 | H319 | |||||||||
| C12–15 Pareth-11 | 68131-39-5 | Xi | R22 | EyeDam1 | H318 | 0.1–15 | 5 | PP, FC, GPC | 58 | |
| Xn | R41 | AquaticAcute1 | H400 | |||||||
| N | R50 | AcuteTox4 | H302 | |||||||
| Diethylene glycol mono- | 112-34-5 | Xi | R36 | EyeIrrit.2 | H319 | 5–30 | 5 | FC, SRP, PP | 59–61 | |
| Ethylene glycol | 107-21-1 | Xn | R22 | AcuteTox4 | H302 | 1–20 | 5 | GPC, FC, PP | 62–64 | |
| Ethylene glycol mono- | 111-76-2 | Xi | R20 | SkinIrrit.2 | H315 | 1–20 | 5 | GPC, FC, GC | 65–67 | |
| Xn | R21 | EyeIrrit.2 | H319 | |||||||
| R22 | SkinSens.1 | [H302, H312, H332] | ||||||||
| R36 | AcuteTox4 | |||||||||
| R38 | ||||||||||
| PEG-10 tridecyl ether | 24938-91-8 | Xi | R41 | EyeDam1 | H318 | 1–15 | 5 | FC, PP, GPC | na | |
| N | R50 | |||||||||
| Phenoxyethanol | 122-99-6 | Xi | R22 | AcuteTox4 | H302 | 1–10 | 5 | PP, FC, GPC | 68 | |
| Xn | R36 | EyeIrrit2 | H319 | |||||||
| Poly(oxy-1,2-ethanediyl), alpha-isodecyl-omega-hydroxy- | 61827-42-7 | Xi | R22 | na | na | 1–15 | 5 | GPC, PP, OSC | na | |
| Xn | R41 | |||||||||
| Sulfamic acid | 5329-14-6 | Xi | R36/38 | SkinIrrit2 | H315 | 3–15 | 5 | SRP | na | |
| R52/53 | EyeIrrit.2 | H319 | ||||||||
| AquaticChronic3 | H412 | |||||||||
| Poly(oxy-1,2-ethanediyl), alpha-isodecyl-omega-hydroxy- | 107-98-2 | na | R10 | Flam.Liq.3 | H226 | 0.1–<10 | 4 | FC, CC, GPC | na | |
| Phosphoric acid | 7664-38-2 | C | R34 | SkinCorr.1B | H314 | 5–30 | 4 | GPC, SRP | na | |
| Met.Corr.1 | H290 | |||||||||
| Poly(oxy-1,2-ethanediyl), alpha-sulfo-omega-hydroxy-, C10–16-alkylethers, sodium salts | 68585-34-2 | Xi | R38 | EyeDam1 | H318 | 1–15 | 4 | GC, BC, KC, GPC | na | |
| R41 | SkinIrrit.2 | H315 | ||||||||
| Sodium ethasulfate | 126-92-1 | Xi | R22 | EyeDam1 | H318 | 1–5 | 4 | FC, BC | na | |
| Xn | R38 | SkinIrrit.2 | H315 | |||||||
| R41 | ||||||||||
| Tri(2-butoxyethyl) phosphate | 78-51-3 | na | na | na | na | 1–5 | 4 | PP | 69 | |
| Alkylalkoholalkoxylat | na | Xi | R36 | SkinIrrit2 | H315 | 1–10 | 4 | FC, GPC | na | |
| R38 | EyeIrrit.2 | H319 | ||||||||
| Alcohols, C10–12, ethoxylated propoxylated | 68154-97-2 | N | R51 | AquaticChronic2 | H411 | 1–5 | 3 | SRP, FC | na | |
| R53 | ||||||||||
| Alpha-terpineol | 98-55-5 | Xi | R22 | SkinIrit.2 | H315 | 0.01–15 | 3 | GPC, GC | 33, 70, 71 | |
| Xn | R41 | |||||||||
| R38 | ||||||||||
| Ammonium hydroxide | 1336-21-6 | C | R34 | SkinCorr.1B | H314 | 0.01–1 | 3 | PP, GPC | 72 | |
| N | R50 | AquaticAcute1 | H400 | |||||||
| Cyclohexanol, 4-(1,1-dimethylethyl)-, 1-acetate | 32210-23-4 | N | R51/53 | AquaticChronic2 | H411 | 0.1–<5 | 3 | GPC, CC | na | |
| ( | 5989-27-5 | Xi | R10 | Flam.Liq3 | H226 | 0.1–1 | 3 | GC, CC | 73–75 | |
| N | R38 | AquaticAcute1 | H400 | |||||||
| R43 | AquaticChronic1 | H410 | ||||||||
| R50/53 | SkinIrrit.2 | H315 | ||||||||
| SkinSens.1 | H317 | |||||||||
| Genapol X 080 | 9043-30-5 | Xi | R22 | EyeDam1 | H318 | 0.1–5 | 3 | PP, GPC | na | |
| Xn | R41 | AcuteTox4 | H302 | |||||||
| R51 | ||||||||||
| R53 | ||||||||||
| Hydrocarbons, terpene processing by-products | 68956-56-9 | Xn | R51/53 | Asp.Tox.1 | H304 | 0.01–1 | 3 | GC, GPC | na | |
| N | R65 | AquaticChronic2 | H411 | |||||||
| Fatty acids, coconut oil, potassium salts | 61789-30-8 | Xi | R36/38 | EyeIrrit2 | H319 | 1–5 | 3 | GPC, FC | na | |
| SkinIrrit.2 | H316 | |||||||||
| Naphtha (petroleum), hydrotreated heavy | 64742-48-9 | Xn | R10 | na | na | 3–>30 | 3 | GPC, FC | 76 | |
| R65 | ||||||||||
| R66 | ||||||||||
| Silicic acid, disodium salt, pentahydrate | 10213-79-3 | C | R34 | SkinCorr1B | H314 | 1–15 | 3 | KC, FC | na | |
| Xi | R37 | STOTSE3 | H335 | |||||||
| Sodium hydroxide | 1310-73-2 | C | R35 | SkinCorr.1A | H314 | 0.01–10 | 3 | FC, GC, KC | 77 | |
| Alkylalkoholethoxylat | na | Xi | R22 | na | na | <5–15 | 2 | FC, GPC | na | |
| Xn | R41 | |||||||||
| 1-Propoxy-2-propanol | 1569-01-3 | na | R10 | Flam.Liq3 | H226 | 1–50 | 2 | GC, GPC | 78 | |
| EyeIrrit2 | H319 | |||||||||
| Nerol | 106-25-2 | F | R12 | SkinIrrit2 | H315 | 0.01–10 | 2 | GC, GPC | 79–81 | |
| Xi | R38 | Flam.Gas1 | H220 | |||||||
| Press.Gas | H280 | |||||||||
| 2- | 88-41-5 | N | R51, R53 | AquaticChronic2 | H411 | 0.1–1 | 2 | CC, BC | na | |
| Alanine, | 164462-16-2 | na | na | na | na | 1–<5 | 2 | CC, FC | na | |
| Alkanes, C9–12-iso- | 90622-57-4 | Xn | R10 | na | na | 30–75 | 2 | CC, FC | 82 | |
| R53 | ||||||||||
| R65 | ||||||||||
| R66 | ||||||||||
| Coconut acid | 61788-47-4 | Xi | R36/38 | SkinCorr.1B | H314 | na | 2 | GPC, FC | 83 | |
| EyeDam1 | H318 | |||||||||
| AcuteTox4 | H302 | |||||||||
| AquaticAcute1 | H400 | |||||||||
| Decyl | 54549-25-6 | Xi | R36 | na | na | 1–5 | 2 | KC, SRP | na | |
| Diphosphoric acid, tetrapotassium salt | 7320-34-5 | Xi | R36 | EyeIrrit.2 | H314 | 1–3 | 2 | GPC, FC | na | |
| Heptane | 142-82-5 | F | R11 | Flam.Liq.2 | H225 | 5–20 | 2 | CC | 84, 85 | |
| Xn | R38 | Asp.Tox.1 | H304 | |||||||
| N | R50/53 | AquaticAcute1 | H400 | |||||||
| R65 | AquaticChronic1 | H410 | ||||||||
| R67 | SkinIrrit.2 | H315 | ||||||||
| STOTSE3 | H336 | |||||||||
| Isobutane | 75-28-5 | F+ | R12 | Flam.Gas1 | H220 | 3–20 | 2 | CC | 86 | |
| Press.Gas | H281 | |||||||||
| Linalool | 78-70-6 | Xi | R38, R43 | SkinIrrit2, SkinSens.1 | H315, H317 | 0.01–3 | 2 | GC, CC | 87, 88 | |
| Non-ionic tensides | na | Xi | R22 | na | na | 5–30 | 2 | FC | na | |
| Xn | R38 | |||||||||
| N | R50 | |||||||||
| Oxirane, methyl, polymer and oxibane, butyl ether | 9038-95-3 | Xn | R22 | AcuteTox4 | H302 | 3–10 | 2 | FC | na | |
| Polymer dispersion | na | na | na | na | na | na | 2 | PP | na | |
| Quaternary ammonium compounds, benzyl-C12–16-alkyldimethyl, chlorides | 68424-85-1 | C | R21/22 | SkinCorr.1B | H314 | 3–10 | 2 | GPC | na | |
| N | R34 | AquaticAcute1 | H400 | |||||||
| PEG-15 cocoate | 61791-29-5 | Xi | R36 | na | na | 1–5 | 2 | FC, GPC | na | |
| Sodium chloride | 7647-14-5 | C | R34 | SkinCorr.1B | H314 | 0.01–10 | 2 | GC, SRP | ||
| Sulfuric acid, mono-C12–16-alkyl esters, sodium salts | 73296-89-6 | Xi | R38 | na | na | 5–15 | 2 | CC | na | |
| R37 | Met.Corr.1 | H290 | ||||||||
| STOTSE3 | H335 | |||||||||
| ( | 687-47-8 | Xi | R10 | EyeDam1 | H318 | 3–10 | 1 | CC | ||
| R37 | Flam.Liq.3 | H226 | ||||||||
| R41 | STOTSE3 | H335 | ||||||||
| 1,4-Dioxacycloheptadecane-5,17-dione | 105-95-3 | N | R10 | na | na | <5 | 1 | GPC | ||
| R51 | ||||||||||
| R53 | ||||||||||
| 1-Penten-3-one, 1-(2,6,6-trimethyl-2-cyclohexen-1-yl)- | 7779-30-8 | N | R51/53 | AquaticChronic2 | H411 | 0.1–1 | 1 | CC | ||
| 2-Diethylaminoethanol | 100-37-8 | C | R10 | SkinCorr.1B | H314 | 1–3 | 1 | GPC | ||
| R20/21/22 | Flam.Liq.3 | H226 | ||||||||
| R34 | AcuteTox4 | [H302, H312, H332] | ||||||||
| 2-Trans-3,7-dimethyl-2,6-octadien-1-ol | 106-24-1 | na | R38 | EyeDam1 | H318 | 0.01–0.1 | 1 | GC | ||
| R41 | SkinSens.1 | H317 | ||||||||
| R43 | SkinIrrit.2 | H315 | ||||||||
| 3,7-Dimethyl-6-octen-1-ol | 106-22-9 | Xi | R38 | SkinIrrit2 | H315 | <0.01 | 1 | GC | ||
| N | R43 | SkinSens1 | H317 | |||||||
| R51/53 | AquaticChronic2 | H411 | ||||||||
| 6-Octenenitrile, 3,7-dimethyl- | 51566-62-2 | na | R52/53 | AquaticChronic3 | H412 | 0.01–0.1 | 1 | GC | ||
| Acetyl cedrene | 32388-55-9 | N | R50/53 | AquaticAcute1 | H400 | 0.1–1 | 1 | CC | ||
| AquaticChronic1 | H410 | |||||||||
| Alcohols, C12–18, ethers with polyethylene glycol mono-Bu ether | 146340-16-1 | N | R50 | SkinIrrit2 | H315 | 1–5 | 1 | FC | ||
| Xi | R38 | AquaticAcute1 | H400 | |||||||
| Acid blue 3 | 3536-49-0 | na | na | na | na | <0.01 | 1 | GC | ||
| Alcohols, C10–16, ethoxylated propoxylated | 69227-22-1 | Xi | R22 | na | na | 5–15 | 1 | FC | ||
| Xn | R41 | |||||||||
| Alcohols, C16–18 and C18–unsatd., ethoxylated | 68920-66-1 | Xn | R22 | EyeDam1 | H318 | 1–3 | 1 | PP | ||
| N | R38 | AquaticAcute1 | H400 | |||||||
| R41 | AcuteTox4 | H302 | ||||||||
| R50 | SkinIrrit.2 | H315 | ||||||||
| Alkyletherphosphatesodiumsalt | na | Xi | R36 | na | na | 1–5 | 1 | SRP | ||
| R38 | ||||||||||
| Alpha- | 125590-73-0 | Xi | R41 | EyeDam1 | H318 | 3–10 | 1 | BC | ||
| Alpha-isomethylionone | 127-51-5 | Xi | R43 | SkinSens1 | H317 | 0.1–1 | 1 | CC | ||
| R52/53 | AquaticChronic3 | H412 | ||||||||
| Alpha-methyl-4-(1-methylethyl)benzenepropanal | 103-95-7 | Xn | R38 | Repr.2 | H361 | 0.1–1 | 1 | CC | ||
| N | R43 | SkinIrrit.2 | H315 | |||||||
| R51/53 | SkinSens.1 | H317 | ||||||||
| R62 | AquaticChronic2 | H411 | ||||||||
| Amides, coconut oil, | 68784-08-7 | Xi | R41 | na | na | na | 1 | CC | ||
| Amyl salicylate | 2050-08-0 | N | R51/53 | na | na | <5 | 1 | GPC | ||
| Anethole, trans | 4180-23-8 | N | R51/53 | na | na | <5 | 1 | GPC | ||
| Aromatic naphtha, type I | 64742-95-6 | Xi | R10 | na | na | 0.1–1 | 1 | FC | ||
| Xn | R37 | |||||||||
| N | R53 | |||||||||
| R65 | ||||||||||
| R66 | ||||||||||
| R67 | ||||||||||
| R51 | ||||||||||
| Benzaldehyde | 100-52-7 | Xn | R22 | na | na | na | 1 | GPC | ||
| Benzenesulfonic acid, 4-C10–13-sec-alkyl derivs. | 85536-14-7 | C | R22 | SkinCorr.1C | H314 | 3–10 | 1 | SRP | ||
| R34 | AcuteTox4 | H302 | ||||||||
| Benzenesulfonic acid, mono-C10–13-alkyl derivs., compds. With ethanolamine | 85480-55-3 | Xn | R22 | EyeDam1 | H318 | 3–10 | 1 | FC | ||
| R38 | AcuteTox4 | H302 | ||||||||
| R41 | SkinIrrit.2 | H315 | ||||||||
| Benzenesulfonic acid, mono-C10–13-alkyl derivs., sodium salts | 90194-45-9 | Xn | R22 | EyeDam1 | H318 | 3–10 | 1 | GPC | ||
| R38 | AcuteTox4 | H302 | ||||||||
| R41 | SkinIrrit.2 | H315 | ||||||||
| Benzyl acetate | 140-11-4 | Xi | R36/37/38 | SkinIrrit.2 | H315 | oct.20 | 1 | CC | ||
| EyeIrrit.2 | H319 | |||||||||
| STOTSE3 | H335 | |||||||||
| Benzyl benzoate | 120-51-4 | Xn | R22 | AcuteTox4 | H302 | 1–3 | 1 | CC | ||
| N | R51/53 | AquaticChronic2 | H411 | |||||||
| Benzyl salicylate | 118-58-1 | Xi | R43 | SkinSens1 | H317 | 0.1–1 | 1 | CC | ||
| N | R51/53 | AquaticChronic2 | H411 | |||||||
| Beta-pinene | 127-91-3 | Xn | R65 | SkinCorr.1B | H314 | na | 1 | PGPC | ||
| N | R50 | EyeDam1 | H318 | |||||||
| R53 | AcuteTox4 | H302 | ||||||||
| AquaticAcute1 | H400 | |||||||||
| Butanedioic acid, sulfo-, 1-ester with | 25882-44-4 | Xi | R36/38 | SkinIrrit2 | H315 | 3–10 | 1 | CC | ||
| EyeIrrit.2 | H319 | |||||||||
| C11–15 Pareth-20 | 68131-40-8 | Xi | R22 | na | na | 1–5 | 1 | GPC | ||
| Xn | R41 | |||||||||
| Camphene | 79-92-5 | F | R11 | SkinCorr.1B | H314 | na | 1 | FC | ||
| Xi | R36 | EyeDam1 | H318 | |||||||
| N | R50 | AcuteTox4 | H302 | |||||||
| R53 | AquaticAcute1 | H400 | ||||||||
| Citral | 5392-40-5 | Xi | R38 | SkinIrrit2 | H315 | 0.01–0.1 | 1 | GC | ||
| R43 | SkinSens.1 | H317 | ||||||||
| Coumarin | 91-64-5 | Xn | R22 | AcuteTox3 | H301 | 0.1–1 | 1 | CC | ||
| R43 | SkinSens.1 | H317 | ||||||||
| 68515-73-1 | Xi | R41 | na | na | 1–5 | 1 | BC | |||
| Diethylene glycol monomethyl ether | 111-77-3 | na | R63 | na | na | na | 1 | PP | ||
| Dimethyl ether | 115-10-6 | F+ | R12 | na | na | 50–75 | 1 | CC | ||
| Disodium phosphate | 7558-79-4 | na | na | na | na | 0.1–1 | 1 | CC | ||
| Ethylene glycol monomontanate | 73138-45-1 | na | na | na | na | 3–10 | 1 | PP | ||
| Eugenol | 97-53-0 | Xi | R36 | EyeIrrit.2 | H319 | 0.1–1 | 1 | CC | ||
| R43 | SkinSens.1 | H317 | ||||||||
| Fatty acids, coco, 2-(2-butoxyethoxy)ethyl esters | 91031-83-3 | Xi | R36 | na | na | 1–5 | 1 | FC | ||
| Fatty acid amides | na | Xi | R38 | na | na | <5 | 1 | GPC | ||
| R41 | ||||||||||
| Galaxolide | 1222-05-5 | N | R50/53 | AquaticAcute1 | H400 | 0.1–1 | 1 | CC | ||
| AquaticChronic1 | H410 | |||||||||
| Hydroxyacetic acid | 79-14-1 | C | R34 | na | na | 1–5 | 1 | SRP | ||
| Isoeugenol | 97-54-1 | Xn | R21/22 | SkinIrrit.2 | H315 | 0.1–1 | 1 | CC | ||
| R36/38 | EyeIrrit.2 | H319 | ||||||||
| R43 | SkinSens.1 | H317 | ||||||||
| AcuteTox4 | [H302, H312] | |||||||||
| Laurylamine dipropylenediamine | 2372-82-9 | C | R22 | AcuteTox.3 | H301 | 0.1–1 | 1 | DP | ||
| N | R35 | SkinCorr.1A | H314 | |||||||
| R48/22 | STOTRE2 | H373 | ||||||||
| R50 | AquaticAcute1 | H400 | ||||||||
| Lilial | 80-54-6 | Xi | R22 | Repr.2 | H361 | <0.01 | 1 | GC | ||
| Xn | R38 | Acute Tox4 | H302 | |||||||
| N | R43 | SkinIrrit.2 | H315 | |||||||
| R62 | SkinSens.1 | H317 | ||||||||
| R51/53 | AquaticChronic2 | H411 | ||||||||
| Lyral | 31906-04-4 | Xi | R43 | SkinSens1 | H317 | 0.1–1 | 1 | CC | ||
| R52/53 | AquaticChronic3 | H412 | ||||||||
| Methanesulfonic acid | 75-75-2 | C | R34 | SkinCorr.1B | H314 | 3–10 | 1 | BC | ||
| Mineral oil | 8012-95-1 | Xn | R65 | 5–15 | 1 | FC | ||||
| Naphtha (petroleum), heavy alkylate | 64741-65-7 | Xn | R10 | AcuteTox.3 | H331 | >75 | 1 | PP | ||
| R53 | Asp.Tox.1 | H304 | ||||||||
| R65 | Flam.Liq.3 | H226 | ||||||||
| R66 | AquaticChronic4 | [H413, EUH006] | ||||||||
| Natriumlaurylethoxylsulfate | na | Xi | R38 | na | na | <5 | 1 | GPC | ||
| R41 | ||||||||||
| 27252-75-1 | Xi | R41 | na | na | 1–5 | 1 | FC | |||
| Pentapotassium triphosphate | 13845-36-8 | Xi | R36/38 | na | na | 5–15 | 1 | GPC | ||
| Phenol, 2-methoxy-4-propyl- | 2785-87-7 | Xi | R36 | EyeIrrit.2 | H319 | 0.1–1 | 1 | CC | ||
| R43 | SkinSens.1 | H317 | ||||||||
| Poly(oxy-1,2-ethanediyl), alpha-sulfo-omega-hydroxy-, C12–14-alkyl ethers, sodium salts | 68891-38-5 | Xi | R38 | EyeDam1 | H318 | <10 | 1 | FC | ||
| R41 | SinIrrit.2 | H315 | ||||||||
| Poly(oxy-1,2-ethanediyl), alpha-(2-propylheptyl)-omega-hydroxy- | 160875-66-1 | Xi | R41 | EyeDam1 | H318 | 03–10 | 1 | FC | ||
| Polyoxyl 20 cetostearyl ether | 68439-49-6 | N | R41 | na | na | 0.1–1 | 1 | PP | ||
| R50 | ||||||||||
| Potassium hydroxide | 1310-58-3 | C | R22 | na | na | 1–5 | 1 | FC | ||
| Xn | R35 | |||||||||
| Silicon dioxide | 7631-86-9 | na | na | na | na | 0.1–1 | 1 | CC | ||
| Sodium 2-butoxyethyl sulfate | 67656-24-0 | Xi | R36/38 | na | na | 1–5 | 1 | FC | ||
| Sodium benzoate | 532-32-1 | na | na | na | na | 0.1–1 | 1 | CC | ||
| Sodium carbonate | 497-19-8 | Xi | R36 | EyeIrrit.2 | H319 | 1–3 | 1 | DP | ||
| Sodium sulfate | 7757-82-6 | na | na | na | na | 0.01–0.1 | 1 | GC | ||
| Solvent naphtha (petroleum), heavy arom. | 64742-94-5 | Xn | R51/53 | Asp.Tox.1 | H304 | 0.1–1 | 1 | PP | ||
| N | R65 | STOTSE3 | H336 | |||||||
| R66 | AquaticChronic2 | [H411, EUH006] | ||||||||
| Solvent naphtha (petroleum), medium aliph. | 64742-88-7 | Xn | R10 | na | na | 25–50 | 1 | OSC | ||
| R56 | ||||||||||
| Sulfuric acid, mono-C10–16-alkyl esters, sodium salts | 68585-47-7 | Xi | R38 | EyeDam1 | H318 | 3–10 | 1 | CC | ||
| R41 | SkinIrrit.2 | H315 | ||||||||
| Sulfuric acid, mono-C12–14-alkyl esters, sodium salts | 85586-07-8 | Xi | R38 | na | na | na | 1 | CC | ||
| R41 | ||||||||||
| Sulfuric acid, mono-C12–16-alkyl esters, sodium salts | 73296-89-6 | Xi | R38 | na | na | 5–15 | 2 | CC | ||
| R41 | ||||||||||
| Sodium C14–16 olefin sulfonate | 68439-57-6 | Xi | R38 | SkinIrrit.2 | H315 | 1–5 | 1 | CC | ||
| R41 | EyeDam1 | H318 | ||||||||
| Terpinolene | 586-62-9 | Xn | R10 | na | na | <5 | 1 | GPC | ||
| N | R51/53 | |||||||||
| R65 | ||||||||||
| Triethanolamine | 102-71-6 | Xi | R36/38 | na | na | 1–5 | 1 | GPC | ||
| Waxmixture | na | na | na | na | na | na | 1 | PP | ||
NA: not available; FC: floor cleaner; GPC: general purpose cleaner; PP: polishing product; CC: carpet cleaner; SRP: scale removing product; BC: bathroom cleaner; GC: glass cleaner; DP: disinfection product; KC: kitchen cleaner; OSC: other surfaces cleaner.
1 Directives 1999/45/EC and 67/548/EEC.
2 Regulation (EC) No. 1272/2008.
3 Information about amount and frequency in selection of professional cleaning product.
4 Studies about substances listed in Table 1, when substances where present in at least two cleaning products.
5 Danger letter.
6 Risk-phrase.
7 Hazard class.
8 Hazard statement.
9 Amount of substance in selected professional cleaning products.
10 Number of selected professional cleaning products that contain the listed chemical substance.
Fraction of selected cleaning products (%) that contain the listed chemical substance
| Substance name | |
| Linalool | 20 |
| Butylphenyl methylpropional | 16 |
| Benzisothiazolinone | 16 |
| Hexyl cinnamal | 15 |
| Limonene | 14 |
| Methylisothiazolione | 12 |
| Aliphatic carbohydrates | 9–10 |
| Amyl cinnamal | 9–10 |
| Benzyl salicylate | 9–10 |
| Citronellol | 9–10 |
| Formaldehyde deposit alpha mixture with 5-chloro-2-methyl-2H-isothiazol-3-one 2-methyl-2H-isothiazol-3-one | 9–10 |
| Hydroxycitronellol | 9–10 |
| Hydroxyisohexyl 3-cyclohexene carboxyaldehyde | 9–10 |
| Isoeugenol | 9–10 |
| Sodium hydroxymethylglycinate | 9–10 |
| Alpha-isomethyl ionone | <7 |
| Benzyl alcohol | <7 |
| Benzyl benzoate | <7 |
| Cinnamal, citral | <7 |
| Coumarin | <7 |
| Eugenol | <7 |
| Geraniol | <7 |
| Glutaral | <7 |
| Octylisothiazolinone | <7 |
| Phenoxyethanol | <7 |
Figure 2Percentages of products by product categories containing at least one substance labeled as corrosive (C), irritant (Xi), and harmful (Xn) in section 3 of SDSs. Floor cleaner (FC), general purpose cleaner (GPC), polishing product (PP), carpet cleaner (CC), scale removing product (SRP), bathroom cleaner (BC), glass cleaner (GC), disinfection product (DP), kitchen cleaner (KC), and other surfaces cleaner (OSC).
Figure 3Percentages of cleaning products that have been labeled with corrosive (R34, R35), irritant (R36, R37, R38), harmful (R20, R21, R22), sensitizing (R43), and other (R41, R62, R63, R65, R66, R67) R-phrases in section 3 of safety data sheets (SDSs).